Georgia Demetriou - Concepedia

Author

Georgia Demetriou

Also Known As

A Day, Carey, Lisa A., G Demetriou, G Savva Demetriou, G. Demetriou, G. S. Demetriou, G.S. Demetriou, Georgia Demetriou, Georgia S Demetriou, Georgia S. Demetriou

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of the Witwatersrand Bloom Fertility Centre Manipal Academy of Higher Education Instituto Nacional de Cancerología HCG NCHRI Cancer Centre

About

Georgia Demetriou is an author at University of the Witwatersrand specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	207
2	Health Sciences	2	2	344
3	Natural Sciences	1	1	262
4	Biochemistry	1	1	262
5	Gastroenterology	1	1	16

Georgia Demetriou

Publications

863

Citations

H-Index

Page 1

	Year	Citations
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer Ahmad Awada, Rámón Colomer, Kenichi Inoue, JAMA Oncology	2016	310
Salt stress impact on the molecular structure and function of the photosynthetic apparatus—The protective role of polyamines Georgia Demetriou, Christina Neonaki, Eleni Navakoudis, Biochimica et Biophysica Acta (BBA) - Bioenergetics Salt Stress ImpactOsmotic StressBiochemistryPhotochemistryPhotosystems	2007	262
A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen Paul Ruff, Daniel Vorobiof, J. P. Jordaan, Cancer Chemotherapy and Pharmacology Breast OncologyOncologyHealth SciencesCancer ManagementClinical Trials	2009	82
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients Joseph Gligorov, Beyhan Ataseven, Mark Verrill, European Journal of Cancer Breast OncologyMedicinePrimary AnalysisAdjuvant TreatmentBreast Cancer	2017	46
Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network Mahmoud Salama, Lauren Ataman, Fabio Sobral, Journal of Global Oncology	2018	28
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D) Alvaro Moreno‐Aspitia, Eileen Holmes, Christian Jackisch, European Journal of Cancer Clinical TrialsRandomized Controlled TrialDrug TrialMedicineBig 2-06/Alliance	2021	28
Installing oncofertility programs for common cancers in limited resource settings (Repro-Can-OPEN Study): An extrapolation during the global crisis of Coronavirus (COVID-19) pandemic Mahmoud Salama, Lauren Ataman, Marouen Braham, Journal of Assisted Reproduction and Genetics	2020	22
Barriers and Opportunities of Oncofertility Practice in Nine Developing Countries and the Emerging Oncofertility Professional Engagement Network Mahmoud Salama, Lauren Ataman, Fabio Sobral, JCO Global Oncology	2020	21
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes Colin F. Spraggs, Laura R. Parham, Linda P. Briley, The Pharmacogenomics Journal Breast OncologyHepatologyMedicineLiver PhysiologyLapatinib-induced Liver Toxicity	2017	20
Outcomes following small bowel obstruction due to malignancy in the national audit of small bowel obstruction Thomas M Drake, Matthew J. Lee, Adele Sayers, European Journal of Surgical Oncology Surgical OncologyGastrointestinal OncologyColorectal SurgeryMedicineGastroenterology	2019	16

Page 1